ZELIFTAN 6 mg/0,4 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

zeliftan 6 mg/0,4 mg

adamed pharma s.a. - polonia - combinatii (solifenacinum succinat+tamsulosinum) - compr. cu elib. modif. - 6mg/0,4mg - medicamente pt.tratamentul hipertrofiei benigne de prostata antagonisti ai receptorilor alfa-adrenergici

MINGERLAN 6 mg/0,4 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mingerlan 6 mg/0,4 mg

synthon hispania s.l. - spania - combinatii (solifenacinum succinat+tamsulosinum) - compr. cu elib. modif. - 6mg/0,4mg - medicamente pt.tratamentul hipertrofiei benigne de prostata antagonisti ai receptorilor alfa-adrenergici

ORUNGAL 100 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

orungal 100 mg

janssen-cilag spa - italia - itraconazolum - caps. - 100mg - antimicotice de uz sistemic derivati de triazol

Tukysa Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenți antineoplazici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Hepcludex Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale pentru uz sistemic - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Copiktra Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenți antineoplazici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Retsevmo Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenți antineoplazici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.